Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Andrea Natale Added: 3 weeks ago
Dr Andrea Natale (St David's Medical Center, Austin, TX, US) joins us to discuss advanced strategies for atrial fibrillation ablation in challenging patient populations, offering a high-volume operator's perspective on optimising procedural success in contemporary practice.Atrial fibrillation ablation has undergone considerable evolution in recent years, with advances in energy modalities,… View more
Author(s): Usha B Tedrow Added: 3 weeks ago
Dr Usha Tedrow (Brigham and Women's Hospital, Boston, MA, US) discusses contemporary approaches to VT ablation in patients with complex and high-risk substrates, from preprocedural planning and mapping strategy through to long-term management.Interview Questions:How has the approach to VT ablation in high-risk substrates evolved over recent years, and what factors define a patient as high-risk… View more
Author(s): Francesco Santoro Added: 2 months ago
EHRA Congress 2026 — Dr Francesco Santoro (University of Foggia, Foggia, IT) joins us to explore how electrophysiologists can approach risk assessment and decision-making when considering catheter ablation in high-risk ventricular tachycardia patients — a population where the potential benefits of ablation must be carefully weighed against procedural complexity and patient frailty.Interview… View more
Author(s): Ulrich Schotten Added: 1 month ago
HRS Congress 2026 — Prof Ulrich Schotten (Maastricht University, Maastricht, NL) joins us to discuss new findings from the NOAH-AFNET 6 trial examining the distribution of atrial fibrillation burden, its relationship to clinical outcomes, and the effectiveness and safety of anticoagulation based on device reports.NOAH-AFNET 6 (Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial… View more